Metastatic castration-resistant prostate cancer Clinical Trials
Conditions / Metastatic castration-resistant prostate cancer
Delta Trials records 4 clinical trials for Metastatic castration-resistant prostate cancer in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 57 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
4
Total Trials
3
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
57
Study Locations
Browse by location (57 total)
- Augsburg, Germany 2 trialsAll trials in Augsburg, Germany
- Aachen, Germany 2 trialsAll trials in Aachen, Germany
- Essen, Germany 2 trialsAll trials in Essen, Germany
- Munich, Germany 2 trialsAll trials in Munich, Germany
- San Francisco, United States 2 trialsAll trials in San Francisco, United States
- Fulda, Germany 1 trialAll trials in Fulda, Germany
- Halle, Germany 1 trialAll trials in Halle, Germany
- Würzburg, Germany 1 trialAll trials in Würzburg, Germany
- Bonn, Germany 1 trialAll trials in Bonn, Germany
- Regensburg, Germany 1 trialAll trials in Regensburg, Germany
- Cologne, Germany 1 trialAll trials in Cologne, Germany
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Frankfurt (Oder), Germany 1 trialAll trials in Frankfurt (Oder), Germany
- Chemnitz, Germany 1 trialAll trials in Chemnitz, Germany
- Middlesbrough, United Kingdom 1 trialAll trials in Middlesbrough, United Kingdom
- Ulm, Germany 1 trialAll trials in Ulm, Germany
- Tübingen, Germany 1 trialAll trials in Tübingen, Germany
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Cottbus, Germany 1 trialAll trials in Cottbus, Germany
- Herford, Germany 1 trialAll trials in Herford, Germany